APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,898,934 | -69.4% | 75,400 | -59.6% | 0.56% | -35.0% |
| Q3 2022 | $12,758,220 | +169.8% | 186,800 | +78.7% | 0.87% | +55.8% |
| Q2 2022 | $4,728,000 | -39.3% | 104,555 | -31.8% | 0.56% | +153.9% |
| Q1 2022 | $7,794,000 | -64.0% | 153,400 | -76.6% | 0.22% | -66.6% |
| Q3 2021 | $21,648,000 | +144.5% | 656,800 | +368.8% | 0.66% | +108.9% |
| Q2 2021 | $8,854,000 | +1231.4% | 140,100 | +803.9% | 0.31% | +1747.1% |
| Q1 2021 | $665,000 | -26.6% | 15,500 | -48.3% | 0.02% | -50.0% |
| Q3 2020 | $906,000 | – | 30,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |